Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib combinations in BRCA-mutated metastatic breast cancer
NCT01506609Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Jan 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 2 trial of veliparib in breast cancer, sponsored by AbbVie Inc.. Started Jan 2012; status: completed.
02
Drugs
veliparib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01506609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506609.